Early transplantation benefits older, higher-risk MDS patients in study

12/13/2011 | MDSBeacon.com

Older patients with higher-risk myelodysplastic syndromes who received early stem cell transplantation and reduced-intensity chemotherapy survived longer than those who did not receive transplants, a study found. Researchers also said older patients with lower-risk MDS should not get early stem cell transplantation unless their quality of life is considerably diminished.

View Full Article in:

MDSBeacon.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX